Skip to main content

Table 5 Seroprevalences of IgG+ and IgM+ antibodies to leptospirosis relative to clinical symptoms in the refugee population; * significant at 0.05

From: Prevalence of anti-Leptospira antibodies and associated risk factors in the Malaysian refugee communities

 

IgG

IgM

% (95% CL)

P-value

% (95% CL)

P-value

Headache*

 Yes (n = 251)

0.8 (0.3–2.2)

0.001

22.7 (18.9–27.0)

0.552

 No (n = 182)

6.0 (2.8–12.0)

 

20.3 (13.6–28.8)

 

Jaundice

 Yes (n = 39)

2.6 (0.2–13.6)

0.863

23.1 (12.1–38.9)

0.829

 No (n = 394)

3.0 (1.5–5.9)

 

21.6 (16.9–26.9)

 

Myalgia

 Yes (n = 176)

2.3 (0.6–7.1)

0.454

21.6 (14.9–30.1)

0.961

 No (n = 257)

3.5 (2.1–5.8)

 

21.8 (18.0–26.1)

 

Chills

 Yes (n = 125)

0.8 (0.1–3.7)

0.055

22.4 (16.5–29.5)

0.825

 No (n = 308)

3.9 (2.2–6.5)

 

21.4 (17.3–26.1)

 

Fever*

 Yes (n = 235)

0.9 (0.3–2.3)

0.003

21.3 (17.6–25.4)

0.812

 No (n = 198)

5.6 (2.4–11.9)

 

22.2 (15.0–31.6)

 

Diarrhea

 Yes (n = 82)

2.4 (0.4–10.0)

0.734

29.3 (19.1–41.8)

0.073

 No (n = 351)

3.1 (1.6–5.8)

 

19.9 (15.8–24.9)

 

Abdominal discomfort

 Yes (n = 143)

3.5 (1.4–7.9)

0.676

25.9 (19.2–33.6)

0.144

 No (n = 290)

2.8 (1.5–5.0)

 

19.7 (15.8–24.1)

 
  1. *Significance values from Log-Linear Models